Pritesh Patel
Interventional Pain Medicine · Dallas, TXNPI 1356695688
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Spinal Simplicity, LLC at 41.8% of the total. Reporting peaked in 2022 at $8,508 and has fallen 87.7% since, to $1,044 in 2025.
Across 286 payments — averaging $83.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$10K
- Medtronic$5K
- Nevro Corp.$3K
- Abbott$2K
- Curonix LLC$874
- Stimwave Technologies Incorporated$427
- plus $2K from 23 others
What the payments were for
- Travel & lodging$4,07217%
- Food & beverage$11,27347%
- Education$8,44435%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 14 | $9,955 |
| Medtronic(2 entities) | 70 | $5,033 |
| Nevro Corp. | 31 | $2,778 |
| Abbott | 71 | $2,334 |
| Curonix LLC | 16 | $874 |
| Stimwave Technologies Incorporated | 10 | $427 |
| Boston Scientific | 4 | $287 |
| Biohaven Pharmaceuticals, Inc. | 4 | $268 |
| Nalu Medical, Inc. | 4 | $211 |
| Amgen | 12 | $206 |
| VGI Medical, LLC | 2 | $189 |
| Collegium Pharmaceutical, Inc. | 9 | $186 |
| Biodelivery Sciences International, Inc. | 10 | $148 |
| Vertex | 1 | $125 |
| Si-bone, Inc. | 2 | $107 |
| GRT US Holding, Inc. | 1 | $104 |
| Pfizer | 5 | $89 |
| Pacira Therapeutics, Inc. | 4 | $75 |
| Zimmer Biomet | 1 | $74 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $56 |
| Scilex Pharmaceuticals Inc. | 2 | $46 |
| Arbor Pharmaceuticals, Inc. | 3 | $39 |
| Relievant Medsystems, Inc. | 1 | $36 |
| AstraZeneca | 1 | $32 |
| AbbVie | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Valinor Pharma, LLC | 1 | $19 |
| SPR Therapeutics, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$9,734
- INTELLIS$1,634
- Omnia$1,589
- SYNCHROMEDII$815
- PROCLAIM$572
- Senza$430
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$382
- Neuromodulation Dspsbls and Accs$269
- INTELLIS ADAPTIVESTIM$247
- NURTEC ODT$236
- StimQ Receiver Stimulator Kit Channel A US w Receiver$231
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$231
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$231
- Freedom 4A Receiver Kit Channel A US w Receiver$231
- Freedom 8A Receiver Kit Channel A US w Receiver$231
- VANTA ADAPTIVESTIM$200
- ETERNA$145
- Senza Spinal Cord Stimulation System$145
- SYNCHROMED$136
- JOURNAVX$125
How this compares
$23,789 in reported general payments places this provider in the 80th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 378 | $11,180 |
| Pregabalin | 111 | $2,505 |
| Gabapentin | 162 | $1,802 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 71 | $1,601 |
| Lidocaine | 15 | $1,459 |
| Tizanidine Hcl | 105 | $1,167 |
| Methocarbamol | 77 | $1,108 |
| Tramadol Hcl | 101 | $958 |
| Cyclobenzaprine Hcl | 86 | $952 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $746 |
| Buprenorphine Hcl | 26 | $521 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 61 | $467 |
| Duloxetine Hcl | 14 | $348 |
| Doxycycline Monohydrate | 18 | $227 |
| Amitriptyline Hcl | 13 | $66 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Dallas
- John MichelsDallas$20K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
- Genaro GutierrezAustin$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.